04.01.2011 • NewsDowCredit Suissechemical industry

Credit Suisse's John McNulty Expects Chemical Industry Revenue to Increase 7% in 2011

Shares of Dow Chemical and other industry rivals rallied on the first trading day of the year after a leading chemical analyst raised several price targets and posted bullish industry expectations for 2011.

"We believe investors would be wise to remain in the chemical space in 2011 as there are a number of factors that are likely to drive the group's earnings and stocks solidly higher over the next 12 to 18 months," Credit Suisse analyst John McNulty wrote in a research note.
Increasing exports to emerging markets, improving balance sheets and cash flow, and commodity inflation should help lift the industry in 2011, said McNulty, who expects industry revenue to increase 7% this year.

Dow, Celanese Corp and Rockwood Holdings offer investors the "most compelling risk-reward" profile, McNulty said. McNulty raised his price target on Dow to $44 from $38, calling it is "top large-cap pick in the chemical space."

Shares of Dow, based in Midland, Mich., jumped 2.9% to $35.14 in late morning trading.

For Celanese, which makes the building blocks for cigarette filters, paints and adhesives, McNulty raised his price target to $55 from $44.
Shares of Celanese rose 3.8% to $42.75.

Shares of commodity chemical producer Rockwood rose 3.8% to $40.61. McNulty raised his target on that company to $51 from $47.
Credit Suisse also boosted its target on Ashland, which owns the iconic Valvoline oil change business, among other properties, to $69 from $62.

Ashland shares rose 3.3% to $52.55.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.